Skip to main content.

Current Projects


Reveal 1 - Kevin Ault, MD
Treatment for Cervical HSIL
Double blind, placebo-controlled phase 3 study of VGX-3100 delivered intramuscularly follow by electroporation for the treatment of HPV16 and/or HPV18 related high grade squamous intraepithelial lesions(HSIL) of the cervix

HPV-201 - Kevin Ault, MD
A Phase 2,randomize, efficacy study of VGX- delivered intramuscularly followed by electroporation alone or in combination with imiquimod, for the treatment of HPV-16 and/or HPV-18 related to high grade squamous intraepithelial lesion(HSIL) of the vulva

Reproductive Endocrinology and Infertility

Mitochondrial RNA defense pathways in the oocyte - Lane Christenson, PhD
Because aging in women is highly associated with reduced fertility, in this proposal we will examine how increased abundance of toxic RNA species is related to mitochondrial function and oocyte quality. We will examine the role of an unexplored post-transcriptional mechanism of RNA regulation, the mitochondrial RNA defense pathway, in oocytes. This research could lead to a breakthrough in our understanding of the process of aging, and how it impacts oocyte quality and fertility in women.
Funding Dates - 04/01/2018 03/31/2023

Role of Follicular Fluid Exosomes on Induction of Ovarian/Fallopian Carcinogenesis - Lane Christenson, PhD
This grant will explore the initial carcinogenic events of ovarian / oviductal cancer and its positive association with the number of times a woman ovulates (i.e., releases follicular fluid) during her lifespan. Follicular fluid is known to induce changes associated with tumorgenesis in oviductal epithelial cells, yet the factors responsible remain unknown. Recently, small membrane vesicles known as exosomes were identified in follicular fluid. We are exploring their role in the carcinogenesis of oviductal epithelial cells in vitro and in vivo.

Trophoblast Progenitors and Pregnancy - Soumen Paul, PhD 
Miscarriage causes termination of 15-20% of implantation-confirmed pregnancies. The majority of miscarriages occur during the first trimester of pregnancy. The defective development of trophoblast cell lineage, which assures embryo implantation and placentation, is one of the leading causes for early pregnancy loss. The goal of this study is to identify the molecular mechanisms involved in trophoblast cell lineage development and determine the association with early pregnancy loss.

Andrology Lab

Epigentic changes to oocyte development in poly cystic syndrome - Katherine Roby, PhD
The aim of this study is to determine how epigenetic factors contribute to abnormal folliculogenesis in polycystic ovarian syndrome(PCOS) and how environmental factors may play a role in PCOS.

Maternal Fetal Medicine

Chronic Hypertension and Pregnant (CHAP) - Marc Parrish, DO
An NIH grant through UAB, randomized treatment of women with mild Chronic Hypertension(<160/105) to be treated early or ACOG standard treatment. It is to test the effectiveness reducing frequency of key adverse maternal and newborn outcomes associated with cHTN including: 1.fetal or neonatal death 2. Preeclampsia with severe features 3. Placenta abruption or indicated preterm birth< 35 weeks 4. SGA (birth wt. < 10 percentile)

Velo Bio - Marc Parrish, DO
Study of Efficacy and Safety of DigiFab in Antepartum Subjects with severe Preeclampsia
A randomized, double blind, placebo-controlled study for the Efficacy and Safety of DigiFab for the prevention of intraventricular hemorrhage, necrotizing enterocolitis, or death. Currently there is not a treatment for severe preeclampsia besides delivery.

KU School of Medicine

University of Kansas Medical Center
Obstetrics and Gynecology
3901 Rainbow Boulevard
Mailstop 2028
Kansas City, KS 66160